Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension
We show that spironolactone use was associated with an increased rate of all-cause hospitalizations, but no difference in hospitalizations for heart failure or pulmonary arterial hypertension, in patients with World Health Organization Group 1 pulmonary arterial hypertension. A possible reason for t...
Main Authors: | Morgan E. Corkish, Lauren T. Devine, Megan M. Clarke, Brian P. Murray, Lisa J. Rose-Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894019868422 |
Similar Items
-
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
by: Nappi J, et al.
Published: (2011-06-01) -
Arterial hypertension and aldosterone
by: V. N. Titov
Published: (2007-12-01) -
Arterial hypertension and aldosterone
by: V. N. Titov
Published: (2007-12-01) -
Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
by: Pieter M. Jansen, et al.
Published: (2011-01-01) -
ENDOTHELIUM RECEPTOR ANTAGONISTS IN PULMONARY ARTERIAL HYPERTENSION: YESTERDAY, TODAY, AND TOMORROW
by: T. V. Martynuk, et al.
Published: (2009-08-01)